I’m not sure whether I really understand what’s at issue here. Why shouldn’t insurers know the resilts of gene tests when setting insurance rates? For example:
Women who inherit damaged versions of the BRCA genes have between 40
and 80 per cent chance of developing breast cancer at some point in
their lives. Approximately one in 850 women in Britain inherit a faulty
BRCA1 gene.
Pretty high probabilities there. Yet:
An alliance of 45 leading charities, unions,
scientists and lawyers will today call on the Government to ban genetic
discrimination. They include the Alzheimer’s Society, Breast Cancer UK,
the Disability Rights Commission, Macmillian Cancer Relief, and Gene
Watch UK, which highlights the ethical questions surrounding genetics.
Dr
Helen Wallace, the deputy director of Gene Watch UK, said: "People
should be able to make the difficult decision about taking a predictive
genetic test on health grounds alone without the fear that it could
affect the financial implications. Genetic testing should not become a
vetting tool for employers and insurance companies."
I could understand (although still might not agree) if being unable to get medical insurance meant that one could not get treatment but that’s not the situation.
At one extreme one can look at it this way. Someone is tested and knows they have the BRCA mutation. They then go and buy shedloads of the various insurances…this is screwing the insurance company which is pricing it on the general population, not the more detailed knowledge held by the individual.
Maybe there is an argument that the insurance companies should not be allowed to use such tests but it hasn’t been explained to me as yet. Anyone want to try?
Leave a Reply